Wellington Management Group
NGNE icon

Wellington Management Group’s Neurogene NGNE Stock Holding History

Wellington Management Group’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$987K Buy
+31,393
New +$864K ﹤0.01% 1748
2025
Q3 		– Sell
-44,904
Closed -$671K – 2059
2025
Q2 		$671K Buy
44,904
+10,483
+30% +$165K ﹤0.01% 1770
2025
Q1 		$403K Buy
34,421
+12,704
+58% +$221K ﹤0.01% 1850
2024
Q4 		$496K Buy
21,717
+3,427
+19% +$128K ﹤0.01% 1833
2024
Q3 		$767K Buy
+18,290
New +$709K ﹤0.01% 1758

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Wellington Management Group's NGNE Position: Q2 2026 in Review

Wellington Management Group opened a new position in Neurogene (NGNE) in Q2 2026: 31,393 shares worth $987K. The stake represents ﹤0.01% of the portfolio and ranks #1748 among its holdings. This is a return to the name: Wellington Management Group previously reported a position in NGNE as recently as Q2 2025.

Wellington Management Group first reported a position in NGNE in Q3 2024 and has held it in 5 quarters since. 112 funds tracked by Wall St. Rank hold NGNE as of Q2 2026.

  • Wellington Management Group held 31,393 shares of Neurogene worth $987K as of Q2 2026.
  • Neurogene was a new Wellington Management Group position in Q2 2026.
  • Neurogene made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1748 holding.
  • Wellington Management Group first reported a position in Neurogene in Q3 2024 and has held it in 5 quarters since.
  • 112 funds tracked by Wall St. Rank held Neurogene as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.